A Russian national accused of helping infect about 80,000 freelance workers with malware has been extradited to the United States and placed in federal custody after appearing in court in San Francisco. Searzhudin Tamirlanovich Aktulaev, 40, was arrested in Cyprus in May 2025 and extradited on August 28, 2026, the US Department of Justice said. He made his initial appearance in federal court on August 31, where […]
A dispute over the term “non-market” lay at the centre of the breakdown between China and the United States at this week’s Group of 20 finance meeting, where Beijing withheld support for a consensus statement backed by the other members. The disagreement emerged during negotiations in Asheville, North Carolina, over language addressing global economic imbalances. People familiar with the talks said the sharpest argument focused on whether […]
Arabian Post Staff -Dubai France and Saudi Arabia have unveiled a €6 billion leisure development near Paris that is expected to include three theme parks, with a flagship attraction built around the Dragon Ball manga and anime universe. The project will be developed around Cergy-Pontoise, about 30 kilometres northwest of the French capital, and is expected to create about 22,000 direct jobs. Qiddiya Investment Company, the Saudi […]
Arabian Post Staff -Dubai Saudi Aramco has signed agreements with French companies carrying a potential combined value of more than $3.7 billion, expanding cooperation in drilling equipment, specialised oilfield products and industrial artificial intelligence. The agreements were announced during a Saudi-French investment roundtable in Paris on Monday, August 24, attended by Aramco president and chief executive Amin H. Nasser. They form part of a broader push by […]
Cybersecurity investigators have linked a supply-chain attack on three widely used Rust software packages to infrastructure associated with North Korean threat actors, raising fresh concerns over attempts to compromise developers before applications are even built. Malicious versions of arrayref, internment and append-only-vec were published on crates. io, the official package registry for the Rust programming language, on August 20. The altered releases introduced a dependency called proc-macro1, […]
Bitcoin climbed above $75,000 on Friday, extending a sharp advance fuelled by improving liquidity conditions, heavy short-covering and renewed optimism over cryptocurrency regulation in the United States. The world’s largest cryptocurrency traded around $75,400 during early Asian hours after reclaiming the level for the first time since late May. Bitcoin gained about 8% over 24 hours and roughly 19% over the week, marking one of its strongest […]
HONG KONG SAR – Media OutReach Newswire – 20 August 2026 – ZJLD Group Inc. (“ZJLD” or the “Company”, together with the Company’s subsidiaries, collectively the “Group”) (SEHK stock code: 06979.HK), a flagship enterprise in China’s baijiu industry and the first baijiu company listed on the Hong Kong Stock Exchange, is pleased to announce its interim financial results for the six months ended 30 June 2026 (“FY 2026 1H” or the “Period”)
In the first half of 2026, the broader baijiu industry operated within a demanding macroeconomic environment characterized by structural adjustments and sluggish consumer demand. In response to cyclical headwinds during the Period, the Group proactively optimized its operational strategies, strengthened healthy channel management, and accelerated digital innovation, resulting in comprehensive stabilization and an operational rebound. The year 2026 marks a pivotal strategic inflection point for ZJLD, signaling the completion of a two-year industry-driven consolidation and the onset of a new high-quality growth cycle.
The key financial and business highlights are as follows:
| FY 2026 1H
(for the six months ended June 30, 2026) (RMB‘000) |
FY 2025 1H
(for the six months ended June 30, 2025) (RMB‘000) |
Changed by | |
| Revenue | 2,546,069 | 2,497,106 | +2.0% |
| Gross profit | 1,520,856 | 1,474,284 | +3.2% |
| Gross profit margin | 59.7% | 59.0% | +0.7percentagepoints |
| Profit attributable to equity holders of the Company | 580,717 | 574,771 | +1.0% |
| Net cash generated from/(used in) operating activities | (234,035) | (322,274) | –27.4% |
| Adjusted net profit (non-IFRS measure) | 626,064 | 613,202 | +2.1% |
| Adjusted net profit margin (non-IFRS measure) | 24.6% | 24.6% | — |
Optimized Product Mix Drives Profitability; Multi-Brand Synergy Amplifies Resilience
Strategic Agility: Pioneering Channel Innovation & Digital Synergy as Dual-Engine
The Group’s proprietary “Premier Retailers Alliance” model and the Monthly Profit-sharing Model (“月月分利模式”) designed for the 5th Generation Zhen 15 have effectively resolved long-standing industry pain points, such as price inversion and distributor margin compression. By establishing competitive monthly margins, automating online ordering, and offering a share-linked sales incentive plan with certain distributors, the Group successfully attracted and retained high-calibre distributors with strong group-selling capabilities and direct access to end consumers. As of 30 June 2026, the Group’s distributor network expanded to 8,993 partners, an increase of 710 from the end of 2025.
Complementing this channel evolution, the Group adopted an omnichannel marketing framework combining “Community Penetration + Digital Empowerment”. Chairman Wu Xiangdong’s executive video channel (“Wu Jindong – ZJLD, 吳金東－珍酒李渡“) and regional cultural livestreams topped the “Entrepreneur Video IP 100 List” (企業家視頻IP100榜單) for seven consecutive months, averaging over one million views per broadcast. This sparked widespread co-created content with members of the Premier Retailers Alliance (萬商聯盟), creating a powerful online-to-offline traffic funnel. Simultaneously, Zhenjiu’s brand value rose to RMB 34.685 billion, a 103% gain over five years, solidifying among China’s top three sauce-aroma baijiu brands.
Forward-Looking AI Integration and Enterprise Digitization
The Group anchors its digital transformation strategy on operational capability and sustainable value creation. During the Period, in partnership with China Unicom, the Group developed an “AI + Expert Blending” framework powered by Large Language Models (LLMs). This synthesis of traditional heritage and advanced AI enables intelligent blending, elevating consistency, efficiency and craft precision. Furthermore, the Group upgraded Da Zhen‘s digital coding system to a “Six-Code” integration architecture, incorporating NFC anti-counterfeiting and ceramic jar storage metrics, as well as an RFID smart case labelling system to track and ensure precise volumetric measurement and end-to-end lifecycle traceability for every Da Zhen product. Zhenjiu was also awarded the national Data Management Capability Maturity Model (DCMM) Level 3 (Robust) accreditation, further validating its AI deployment and digital leadership.
Deepening Operational Foundations to Drive the New High-Quality Growth Cycle
Looking ahead to the second half of 2026 and beyond, ZJLD will maintain strategic poise by extending proven operational frameworks, such as the “Premier Retailers Alliance” and “Monthly Profit-sharing Model” to Zhen 30 and other core product lines. This initiative will precisely activate high-end and mid-tier markets while strengthening portfolio synergies across all price ranges. Concurrently, the Group will deepen its operation-sales decoupling (營銷分離) mechanism, rigorously monitor channel pricing, protect distributor profitability, and prioritize storage facility construction across its five major production facilities, namely Zhen Jiu Mao Tai Shuang Long (茅台鎮雙龍), Zhen Jiu Bai Yan Gou (白岩溝), Zhen Jiu Zhao Jia Gou (趙家溝), Li Du Zheng Jia Shan (鄭家山) and Xiang Jiao Jiang Bei (江北) to reinforce its long-term competitive moat.
Mr. Wu Xiangdong, Founder and Chairman of ZJLD Group, remarked, “Baijiu is a business that demands patience and reverence—time speaks through quality, and authentic fragrance endures. Over two years of industry rebalancing, our distributor partners and we have navigated genuine challenges and hardships; yet this period offered an invaluable window for reflection, consolidation, and self-reinvention. The deeper the valley, the more vital it is to stay grounded and focus on disciplined execution. Our stabilization in the first half of 2026 is the natural reward of diligent work and marks the dawn of a new growth phase. There are no shortcuts in business—only an uncompromising pursuit of quality, continuous market exploration, and adaptability in the face of change. In times of adversity, we chose to brew finer liquor, preserve channel profitability, and deliver utmost sincerity to our consumers. The launch of the ‘Premier Retailers Alliance’ and ‘Monthly Profit-sharing Model’ models ensures that every partner who trusts ZJLD enjoys security, clarity, and equitable rewards amid challenging conditions.
Engaging directly with consumers and merchants through digital broadcasts has reinvigorated my entrepreneurial passion and joy, which I felt when I first entered the baijiu industry. The consumers’ appreciation for fine baijiu remains undiminished, and their yearning for a better life remains passionate. 2026 serves as ZJLD’s springboard for a renewed journey. We remain a dedicated team of idealistic distillers, honoring nature’s harvest, grateful for the passage of time, and optimistic about the industry’s future. ZJLD will move forward with resilience, innovation, and an open heart alongside all our companions—cheers to bright moments and the journey ahead.”
Hashtag: #ZJLDGroup
The issuer is solely responsible for the content of this announcement.
Zhen Jiu was established in 1975 in Zunyi, Kweichow, China’s primary production area of sauce-aroma baijiu. In 1988, it was honored with the National Quality Award at the 5th National Wine Appreciation Conference. In the same year, it was announced by the Protocol Department of the Ministry of Foreign Affairs, the Communication Department of the Ministry of Economy and Trade, and the Great Hall of the People Management Bureau to become one of the two sauce-aroma baijiu served at state banquets. It is also known as one of the “Three Representative Baijiu Brands in Kweichow”.
ZJLD Group Inc. is a leading baijiu group in China devoted to offering premium baijiu products, including sauce-aroma, mixed-aroma, and strong-aroma varieties. According to Frost & Sullivan statistics, the flagship brand Zhenjiu has maintained its position for two consecutive years (2023 and 2024) as the fourth-largest sauce-aroma baijiu brand in China and the third-largest in Guizhou Province, by revenue. The Company operates four baijiu brands in China, including two national baijiu brands, Zhen Jiu and Li Du, and two regional brands, Xiangjiao and Kaikouxiao. ZJLD prides itself on inheriting the time-honored baijiu-brewing techniques and reinvigorating them to develop iconic products. It strives to create a wide variety of aromatic and mellow baijiu products to meet consumers’ diverse preferences, seize broader market opportunities, and promote traditional Chinese baijiu culture.
Matein Khalid I feel as if I am no longer skating on thin ice with the AI bubble on Nasdaq but now tiptoeing on a minefield that could well explode at any moment under my feet. Why this premonition of imminent disaster? It is clear that Iran is going to humiliate President Trump and not do any kind of a deal to open the Strait of Hormuz […]
BANGKOK, THAILAND – Media OutReach Newswire – 18 August 2026 – The Joint Standing Committee on Commerce, Industry, and Banking (JSCCIB), comprising the Thai Bankers’ Association, the Board of Trade of Thailand, and the Federation of Thai Industries, in collaboration with the Ministry of Finance, the Bank of Thailand, the National Economic and Social Development Council (NESDC), and the World Bank, has announced its readiness to convene a high-level leadership conference, ‘The Bangkok Business Summit 2026,’ under the theme ‘Reinvent Thailand, Resilient ASEAN.’
To be held at the Queen Sirikit National Convention Center (QSNCC), the summit will showcase the vision of public-private sector collaboration aimed at restructuring Thailand’s economy. This event serves as a milestone paving the way toward the IMF-World Bank Group Annual Meetings 2026, which Thailand will proudly host in Bangkok in October 2026, as well as Thailand’s upcoming ASEAN Chairmanship in 2028.
A key highlight of The Bangkok Business Summit 2026 includes a keynote address entitled ‘Thailand’s Offer to the World’ by Mr. Anutin Charnvirakul, Prime Minister of Thailand. The address will declare Thailand’s readiness as a global investment hub, shifting the nation from cost-based competition to enhancing capabilities, innovation, and digital infrastructure. Furthermore, Dr. Ekniti Nitithanprapas, Deputy Prime Minister and Minister of Finance, will deliver a policy address on ‘Unlocking the Next Growth Engines for Thailand & ASEAN,’ revealing policy reform steps designed to unlock private sector investment and drive the country’s new economic engines. Professor Dr. Yodchanan Wongsawat, Deputy Prime Minister and Minister of Higher Education, Science, Research and Innovation, will address positioning Thailand as a regional investment platform for high-tech industries.
Mr. Payong Srivanich, Chairman of the Joint Standing Committee on Commerce, Industry, and Banking (JSCCIB), stated that this event aims to answer a critical question: How can Thailand transform global shifts and its central location in ASEAN into new opportunities for investment, job creation, and sustainable growth?
“The Bangkok Business Summit 2026 is not merely a platform for exchanging perspectives, but a venue where Thailand presents its concrete strengths, opportunities, and development directions to the global business community—bridging the government’s vision, recommendations from international organizations, and the practical expertise of the private sector,” Mr. Payong stated.”Thailand’s challenge today is not just growth, but building competitive growth in a rapidly changing world. We need a platform for collaborative efforts to ‘Reinvent Thailand’ by creating new economic engines and elevating our competitiveness so Thailand can capture new opportunities and become an integral part of a ‘Resilient ASEAN’ capable of adapting to global dynamics.”
Key Highlights & Session Overview
Afternoon Tracks
Additionally, the Bangkok Business Summit 2026 will feature a panel discussion titled ‘The Future of Agrifood Business.’ Under the concept of Elevating to a Regional Strategic Asset, leaders from top companies including Sea Value PCL and Olam Agri (Singapore) will share their perspectives on how Thailand’s agrifood industry is evolving beyond its traditional role as the ‘Kitchen of the World’ to become a vital strategic asset for regional food security, and another discussion on ‘The Future of the Human-Centric Economy,’ integrating health, wellness, tourism, and the creative economy centered around people rather than isolated sectors. Panelists include Minor International, Bangkok Dusit Medical Services (BDMS), and Cerecin.
Closing & Actions
To conclude the summit, leaders from the three JSCCIB member organizations will summarize actionable proposals to transform insights into concrete practices. These encompass enhancing competitiveness, building investment ecosystems, and developing future industries. The event will culminate in the signing of a Letter of Intent for Cooperation on the Digital & AI Compact between Thailand’s economic agencies and the World Bank.
Note: Speakers and the event program are subject to change without prior notice due to unforeseen circumstances. We apologize for any inconvenience and appreciate your understanding.
Hashtag: #JSCCIB
The issuer is solely responsible for the content of this announcement.
2Q26 Business and Financial Highlights
Mr. Bobby Sheng, Chairman of Bora Group, stated, “We are pleased to announce Bora Group’s return to strong operating profits and double to triple-digit growth on all key margins sequentially, as well as demonstrate that our soft 1Q26 performance was anomalous rather than structural. Our impressive sequential improvement was driven entirely by strong demand from both our CDMO and Pharma Sales businesses, with 2Q26 manufactured batches reaching 0.38 billion doses, led by increased commercial production in Maple Grove and Zhunan sites and a full quarter of operations in the Maryland injectable facility, while our flagship products DLS and VIGAFYDE® in Pharma Sales continues to secure leading market share.
Our focus right now is execution. CAPEX investments in our mature sites, including facilities in Taiwan and in Canada, continue to deliver operational leverage driven by gross margin expansion, and our recently acquired oral solid dose facility in Maple Grove continues to show stellar and impactful demand as we sign more projects. Our 12-month rolling backlog is at historic high in almost all our sites, despite projected manufacturing delays at our Maryland injectable facility as we diligently respond to FDA audit observations from a recent audit. Bora Group’s commitment to the fast-growing Biologics manufacturing industry took another big step as we look to integrate 12,000 liters of capacity, and 3 commercial products from our Rockville facility, as well as see revenue recognition from this acquisition starting Q3. As Bora’s CDMO footprint expands in the US, we continue to capture durable, high-value demand as customers increasingly prioritize supply security and onshore capacity.
In addition, we are seeing sustained growth and improved gross margins in the Vigabatrin franchise, our most important, rare disease franchise, thanks to renegotiations with our partner vendors. Accelerated state and government orders for generics products increased 2Q26 revenues and 6 new generics launches have also supported a more diversified generics portfolio. Together, the advancement in rare disease franchise and generics business has positioned Bora’s Pharma Sales business, operating under the name Upsher-Smith, in a far stronger state than it was just a quarter ago.
As announced in July, we are excited to be developing a group-wide AI in Manufacturing program, BORA AIM, aimed at improving process efficiency across sites, spanning engineering, quality and production. We also announced a partnership with Insilico Medicine to enhance our understanding of AI drug discovery and create more customized AI manufacturing platforms for AIDD small molecules. In the next 12 months, Bora Group will be ready to showcase some exciting AI-enabled CDMO platforms that will truly add value to our partners and sharpen the overall competitive advantages of Bora Group.
As our momentum carries Bora into the second half of the year, we expect margins of our flagship products in Pharma Sales and CHC businesses to hold steady on continuous revenue growth, and improved efficiencies in the CDMO business in addition to consolidation of new revenues from the Rockville facility.”
2Q26 Operational Achievements & 2026 Outlook
Global CDMO Operations
Revenues increased 30.3% year-over-year and 29.0% quarter-over-quarter including internal orders, and 33.0% and 40.2% external orders only, or NT$2,116.4 million. The growth was primarily driven by a strong rebound in injectables following the semi-annual maintenance in 1Q26 and same period last year, and demand acceleration overall as we continue to meet the increasing backlog.
CDMO business also signed a record high US$378.2 million in total external wins. Highlighted by a 10+2-year, multi product commercial contract in our Maple Grove facility with a new top-20 pharma company, and 14 new molecules from pre-commercial programs from multiple new customers. Bora is confident in its mid- to long-term growth trajectory as pharma and biotech companies continue to look for US based CDMOs as a part of their efforts to onshore US production and improve supply chain resilience.
During the quarter, 0.38 billion doses, or 109 molecules, were developed and manufactured. Contribution from the top 20 global pharmaceutical companies stood at roughly 30% and should increase drastically in the next 8 quarters.
Looking at 3Q26, the Company is highly optimistic, with our backlog having climbed to an unprecedented level even after a strong quarter of manufacturing output. We do anticipate some timing shifts in revenue recognition related to scheduled semi-annual maintenance at our Maryland injectable site, alongside targeted quality-enhancement activities in connection with observations on passive RABS (Restricted Access Barrier System) line received from an FDA audit that took place 2Q26. However, there has been no reduction in total commercial batch productions in 2026 as we speak and several existing clients have initiated transfers to the FlexPro isolator filling lines. RFP activity has risen, with the first GMP PPQ campaign starting in August. On the newest, isolator-based AST lines, factory acceptance testing (FAT) is planned for Q326, with qualification to follow in 2027, expanding our ability to onboard small-scale isolator programs, including tech transfers.
On biologics, Rockville facility revenue recognition started in the first month of 3Q26 and the site has confirmed that it is on track to deliver batch production volumes ahead of last year’s run rate of around 13 batches for the remainder of 2026. We anticipate one-time transaction costs from this acquisition of approximately 3% of the purchase price including legal and FA fee and transition related expenses as stated in the Transition Service Agreement. The Rockville acquisition expands biologics capacity and brings integrated drug substance (DS) and drug product (DP) capabilities under one roof, strengthening our end-to-end service offering and attracting more inbound opportunities and higher value conversion with cross selling opportunities for our injectable business.
For our strategic investment in Tanvex Biopharma, the main Bora Biologics platform company, although the business still operates at a loss, Tanvex has built a strong presence in international conferences, especially Bio International in the US in June. We have seen a positive uptick in pipeline from leading biotechs and heavy weight biopharmas, and stable demand for early-stage PD programs in Zhubei. The Rockville acquisition is expected to orchestrate and accelerate opportunities for Tanvex in the coming quarters.
Pharma Sales Operations
Revenues decreased 2.7% year-over-year and increased 30.4% quarter-over-quarter, arriving at NT$2,934.04 million in 2Q26. The year-over-year decrease was mainly due to a product rationalization program in 2025 that lead to the withdrawal of a basket of legacy generics products.
During the quarter, specialty and brand came in strongly, up 58.8% for the quarter QoQ and displayed almost 50% growth against 2025 run rate. The rare-disease Vigabatrin franchise demand is robust, and our continuous investment in the segment has resulted in much broader patient access compared to when we acquired Upsher-Smith 28 months ago. On coverage, we are on track to achieve year-end formulary goal of >50%, supported by more regional plans and strong physician adoption as they gain experience with VIGAFYDE®. The Company has also renegotiated contracts with suppliers, leading to improved gross margins for the franchise during the quarter and expects full economic contribution starting 3Q26. Simultaneously, the Company out-licensed its non-core assets, Stiripentol generics and 505(b)(2), during the quarter, fully capturing the economic value of these drug assets to enable fueled and renewed focus on core specialty and brand business.
The generics business returned to stability as Upsher-Smith successfully defended flagship product DLS. High value generics advanced 20.6% sequentially from downstream restocking, narrowing the year-to-date YoY decline against 2025 run rate to high teens.
Having executed our way through specialty and brand business growth and generics portfolio optimization, we have returned to the 2023–2024 peaks of Pharma Sales performance but with healthier and more resilient operating profits. As of now, Upsher-Smith sees 6 ANDA pending approval.
CHC Operations
Bora Group has increased holdings of Sunway Biotech to 42.27% through a private placement at $NT 596 million. Subsequently, Sunway completed the acquisition of Weider Global Nutrition (WGN), a global nutritional supplements company with offices in the US, Spain, and Germany and products sold in over 60 countries. Benefitting from the consolidation of WGN that started in May, Consumer Health business totaled NT$824.76 million in 2Q26, a 354.4% increase QoQ and 234.3% YoY. Focusing on longevity and sports nutrition, WGN’s distribution strength is expected to meaningfully contribute to the CHC business in 2026 and beyond and shall deliver vertical-integration synergies to Sunway’s existing ingredients’ manufacturing operations. Together, the WGN acquisition is expected to catapult Sunway Biotech into a leading global nutritional supplements company and substantially accelerate top and bottom-line improvements in the future.
Recent Investor Conference
Bora will host English online earnings call at 8:00 a.m. Taiwan time on Aug. 14th, 2026. The event will cover the Company’s 2Q26 financial and business results and 2H26 outlook.
English Online Earnings Presentation Link: https://teams.microsoft.com/meet/225504163505748?p=UyyncWl1CnOzjBCNKD
Bora will participate in Goldman Sachs 2026 CDMO day in Singapore in Sept. For 1:1 meetings with management, please contact your GS representative.
Bora 2026 Earnings Schedule
Q3 2026: Expected in the 2nd week of Nov 2026
Q4 2026: Expected in the 2nd week of Mar 2027
Hashtag: #BoraGroup
The issuer is solely responsible for the content of this announcement.
Founded in 2007, Bora Pharmaceuticals (“Bora” or “the Company”, 6472.TW and BORAY.OTCQX) is a leading pharmaceutical services company with a vision and goal of “Contributing to Better Health All Over the World”. Operating under a “Dual Engine” model that integrates CDMO and commercial expertise, we empower pharmaceutical and biotech partners to optimize product development, accelerate launches, and scale supply to meet global patient needs. At the same time, we actively broaden R&D and sales infrastructure, focusing on niche and rare disease markets to improve patients’ quality of life.
By investing in talent, infrastructure, and biologics expansion, Bora continues to transform operations and achieve sustainable growth. Committed to making success “certain,” Bora sets new standards in the pharmaceutical and CDMO industries.
For more, please visit:
https://www.bora-corp.com
https://www.boracdmo.com
Disclaimer:
This document and the accompanying information may contain forward-looking statements. All statements regarding the company’s future business operations, potential events, and prospects (including but not limited to forecasts, targets, estimates, and operational plans) are considered forward-looking statements unless they refer to factual occurrences. Forward-looking statements are subject to various factors and uncertainties that may cause significant differences from actual results, including but not limited to price fluctuations, actual demand, exchange rate variations, market share, competitive conditions, changes in the legal, financial, and regulatory framework, international economic and financial market conditions, political risks, cost estimates, and other risks and variables beyond the company’s control. These forward-looking statements are based on current predictions and assessments, and the company disclaims any responsibility for future updates.
Highlights
OVERVIEW
The Group delivered strong performance in an evolving macroeconomic climate, underpinned by disciplined execution and a focus on driving higher returns. A portfolio built on everyday essentials, combined with a strong value proposition with convenience, continues to resonate with customers against the backdrop of oil price volatility. For the first half of 2026, subsidiary LFL sales growth from continuing businesses4 further improved to 3%. This was driven by sustained strong momentum in the Health & Beauty segment, as well as a return to growth in both the Convenience and Home Furnishings businesses. Price reinvestment, supported by a reset in sourcing strategy, drove Food volume growth with Wellcome’s basket price now trading at a discount relative to the Greater Bay Area5, compared to a premium in the prior year.
The Group’s commitment to retail excellence, a lean overhead structure and expanded omnichannel touchpoints enables us to serve our customers with better pricing and better experience. The DFI Omni Platform further strengthens this by seamlessly integrating our extensive store network with digital capabilities, delivering greater convenience and personalisation while unlocking new value pools through rich, cross-format data insights. Developing and scaling high-margin revenue streams, including retail media (DFIQ Media) and insights monetisation (DFIQ Insights), will diversify our profit base and support long-term value creation.
To enhance operational efficiency and improve productivity of team members, the Group introduced GenAI-powered tools in the first half of 2026, with plans to scale deployment across operating markets in the coming months. In parallel, AI capabilities are increasingly embedded across core retail functions, including assortment optimisation, promotion planning and demand forecasting, to drive better, more data-driven decisions.
The Group undertook a thorough review of the cost structure with the aim of driving sustainable savings and improving long-term cost efficiency. This has led to a reallocation of resources and costs toward format-level operations, driving greater agility and responsiveness to evolving market conditions, while continuing to reduce central selling, general and administrative (SG&A) costs through overhead optimisation. Combined with improving digital economics, underlying operating profit from continuing businesses6 grew 14% year-on-year in the first half of 2026. Improved operating performance and lower financing costs contributed to an 11% increase in underlying profit attributable to shareholders, or 44% from continuing businesses7 only.
The Group maintained a healthy balance sheet with a net debt position of US$22 million as of 30 June 2026. Return on capital employed further improved to 12%, up from 9% as of December 2025.
The Group declared an interim dividend of US¢6.20 per share, representing a significant increase of 77% compared to the same period last year. This enhanced interim dividend distribution underscored the Board’s confidence in the Group’s underlying business momentum and strong cash flow generation, while ensuring sufficient capital for future growth in line with our 70% payout policy.
OPERATING PERFORMANCE
Overall
For the first half of 2026, underlying subsidiary revenue from continuing businesses6 was US$4.1 billion, up 4% year-on-year and 3% on a LFL basis. The growth was driven by strong performance in the Health & Beauty division, as well as a return to growth in the Convenience and Home Furnishings segments. Total revenue, including Maxim’s, was US$5.6 billion. Excluding divestments7, total revenue increased by approximately 4%.
Overall underlying profit attributable to shareholders from continuing businesses7 grew 44% year-on-year to US$117 million, primarily driven by improved operating profit and lower financing costs.
Underlying subsidiary profit from continuing businesses6 was US$101 million, reflecting a 49% year-on-year increase, primarily driven by earnings recovery in the Home Furnishings and Food segment with lower SG&A expenses as a result of overhead reduction.
Underlying profit from associates was US$16 million, down from US$30 million in the prior comparable period, which included share of profits from Robinsons Retail ahead of its disposal. Excluding this, profit contribution from associates was up 22% year-on-year due to robust sales growth and effective cost optimisation at Maxim’s.
The Group reported operating cash flow after lease payments of US$178 million, 16% higher than the prior year period, driven by underlying operating profit growth. Free cash flow for the period was a net inflow of US$85 million, down 5% year-on-year, due to increased capex investment in priorities that will further strengthen the Group’s competitive position while driving long-term value for shareholders.
Digital
Capturing a significant share of daily essential customer missions in Hong Kong, the DFI Omni Platform – powered by yuu – enables deeper customer engagement across offline and online touchpoints, maximises data capture and unlocks incremental margin opportunities beyond core retail through DFIQ Media and DFIQ Insights. Overall digital turned profitable, with e-commerce and DFIQ Media contributing to approximately 35% of total revenue growth in the first half of 2026. This was supported by improved underlying e-commerce economics, a rising online sales penetration8 to 6.9% and 3 times in DFIQ Media revenue compared to first half of 2025. As of June 2026, more than 10,000 digital media-ready screens were available across DFI outlets.
Subsidiaries
Sales for the Health & Beauty division were US$1.4 billion, up 8% year-on-year from continuing businesses9, 7% in constant currency, or 6% on a LFL basis, with continued market share gains across key operating markets. Mannings and Guardian deepened their leadership as the trusted advisors for wellness through an enhanced, wellness-focused assortment and continued roll-out of skin and scalp assessment services across a wider store network. The recently announced exclusive distribution partnership with Holland & Barrett, a leading UK health and wellness retailer, will further expand customer access to trusted wellness solutions in Hong Kong and Singapore, followed by a broader rollout across selected Asia markets in the coming years. In Hong Kong and Macau, Mannings delivered 5% LFL sales growth, driven by increased basket size and robust tourist store sales amid higher visitor arrivals. In Southeast Asia, Guardian achieved strong LFL sales growth of 9%, supported by higher basket sizes and improved promotional efficiency, with Indonesia and Vietnam delivering close to 20% LFL growth. Excluding the impact of cost reallocation and closure of Mannings China offline stores, divisional profit increased moderately by 2% to US$109 million. Margin declined primarily due to increased strategic promotions to drive stronger sales and market share in Southeast Asia, particularly in Malaysia where health & beauty retailers did not benefit from the SARA Cash Aid Programme.
Total Convenience sales were US$1.2 billion, up 4% year-on-year or 2% on a LFL basis, as continued growth in higher-margin categories, including ready-to-eat (RTE) and exclusive collectibles, more than offset the decline in lower-margin cigarette volumes. Hong Kong LFL sales returned to growth in the second quarter following ten consecutive quarters of decline, supported by RTE and an expanded non-food assortment, including limited-edition collectibles and K-pop merchandise. Excluding cigarettes, LFL sales were up 3% for the period. In Singapore, effective promotional campaigns and collectible product launches drove strong LFL sales growth of 8%. In South China, continued store network expansion through a capex-light franchise model – including a net addition of 112 stores since June 2025 to nearly 1,980 locations – contributed to 12% sales growth year-on-year or 6% on constant currency basis. LFL sales were 1% higher compared to the prior year period, driven by the successful launch of Own Brand in key categories of frozen products and packaged drinks. The team remains focused on driving footfall and sales through further expansion of the RTE offering across both offline and online channels. This includes a broader rollout of the Food Bar to 453 stores as of June 2026, up from 325 at year-end 2025, and strong overall online sales growth of more than 35%. Excluding cost reallocation impact, profit for the division increased by 2% to reach US$37 million.
Reported sales for the Food division from continuing businesses10 were US$1.1 billion, up 1% year-on-year. LFL sales returned to positive growth of 0.5% in the second quarter of 2026. In Hong Kong, investment in reduced pricing on core basket items, a stronger fresh proposition, and Own Brand offering drove 2% increase in total volume and 0.5% LFL sales growth in the first half of 2026. As of June 2026, Wellcome’s “Everyday Value” range has expanded to nearly 500 items, offering savings of up to 40%, bringing its basket price down from a premium to a discount relative to the Greater Bay Area. The team also accelerated omnichannel growth with more than 35% growth in online order volume. In Cambodia, Lucky reported strong double-digit sales growth, with profit more than doubling year-on-year. The plan to open 50 new stores over the next few years remains on track. Macau Food sales remained challenging as a result of cross-border grocery shopping. Excluding the impact of cost reallocation and the divestment of Singapore Food, overall divisional profit increased by 27% year-on-year to US$17 million.
The Home Furnishings division delivered strong recovery in performance during the first half of 2026, with LFL sales growth of 4%, compared to a decline of 6% in the prior year period. Price reinvestment in core value SKUs, a stronger focus on locally relevant ranges and IKEA Food innovation drove increased footfall and items per baskets, resulting in a 3% LFL sales growth in Hong Kong and 5% in Taiwan. IKEA Food remains a critical traffic and revenue driver, accounting for 15% of total sales. In Indonesia, while offline sales momentum remained soft, LFL sales trend improved on a strengthening IKEA’s omnichannel proposition with online sales penetration reaching 24%. Sales recovery and effective cost optimisation measures contributed to 85% growth in overall divisional profit, excluding cost reallocation impact.
Associates
The Group’s share of Maxim’s underlying profits was US$16 million for the first half of 2026, up 15% year-on-year, underpinned by continued cost optimisation and operational efficiency measures. Sales for the period increased by 4%, driven by strong restaurant performance in Southeast Asia and a return to growth in the Chinese mainland, partially offset by weaker sales in Hong Kong.
RECENT BUSINESS DEVELOPMENTS
On 30 June 2026, the Group announced the acquisition of 100% interest in Cody Hong Kong (Cody HK), one of the leading outdoor advertising solution providers in Hong Kong, for a cash consideration of HK$30.2 million (approximately US$3.8 million) from ARN Media Network Limited (ASX: A1N), subject to customary adjustments.
The acquisition advances DFI’s strategy to build a full-funnel advertising solution in Hong Kong through DFIQ Media. By integrating Cody HK’s strategic assets – including multi-year exclusive advertising rights with Kowloon Motor Bus (KMB) and Hong Kong Tramways (HKT) – with DFI’s extensive store network, growing online user base, and closed-loop measurement capabilities, DFIQ Media strengthens its ability to deliver high-impact advertising solutions to a broader advertiser base across online, in-store, and outdoor channels.
Subject to satisfaction of third-party consents, the transaction is expected to complete in the second half of 2026.
PEOPLE
On 6 July 2026, the Group announced four senior leadership appointments effective from 1 August 2026. These moves reflect the Group’s continued focus on strengthening its leadership pipeline and driving the next phase of growth with experienced, proven leaders.
Andrew Wong will be appointed Chief Executive Officer, DFI IKEA. Formerly CEO of Health & Beauty, Andrew brings extensive experience in driving customer-led growth, operational discipline and in-store digitalisation across multiple markets. His earlier leadership of franchise operations at Jardine Restaurant Group positions him well to lead the IKEA business into its next phase of development.
Curtis Liu, having most recently served as Chief Executive Officer of Food, will be appointed Chief Executive Officer, Health & Beauty. His proven leadership in driving customer value repositioning in Hong Kong, combined with deep operational retail knowledge and digital experience at JD.com, positions him well to drive continued momentum and omnichannel growth in Health & Beauty.
Tom van der Lee will be appointed Chief Executive Officer, Food. Tom has played an instrumental role as Group Chief Financial Officer, driving financial discipline and supporting key strategic decisions across the Group. His prior experience at FrieslandCampina, a global food company, and his broad financial leadership across DFI banners in Southeast Asia supported his strong commercial grounding to lead the Food business.
Kaizhi Wu will succeed Tom as Group Chief Financial Officer. Kaizhi currently serves as Group Finance Director, Planning & Reporting, based in Hong Kong. Prior to joining DFI, he served as Executive Vice President and Chief Financial Officer of Yonghui Superstores Co., and earlier held senior roles at Jardine Matheson, Fosun Group and PwC in London. Kaizhi will join the Group’s Management Committee upon assuming his new role.
OUTLOOK
The Group remains confident in our ability to navigate the evolving trading environment, supported by sharpened business priorities, a strong balance sheet and low-cost operating model. Financial outlook outlined at the Investor Day in December 2025 remains intact as DFI continues to execute our multi-year strategic initiatives that are critical to driving sustainable revenue and earnings growth. These initiatives include strengthening our value proposition, strategically expanding store network, enhancing omnichannel capabilities and accelerating digital asset monetisation through data-driven insights. In particular, the growing DFI Omni Platform will deepen our customer engagement, further reinforce our core retail strength and enhance overall earnings resilience in the long term.
Despite an elevated oil price outlook for the remainder of the year, the Group expects to deliver stronger profitability supported by enhanced operational efficiency. As a result, the Group revises up its full-year organic revenue growth11 outlook to be between 3.0% and 4.0% (up from previously 2.0% to 3.0%), and underlying profit attributable to shareholders to be between US$285 million and US$305 million (up from previously US$270 million and US$300 million).
Scott Price
Group Chief Executive
—————–
1 Excluding impacts of divestment of Singapore Food business, closure of Mannings China and disposal of minority stake of Robinsons Retail
2 Excluding impacts of divestment of Singapore Food business and closure of Mannings China
3 Excluding Singapore Food and Mannings China
4 Excluding impacts of divestment of Singapore Food business and closure of Mannings China
5 Based on a third-party assured price comparison of a 200-item comparable basket between DFI and Shenzhen
6 Excluding impacts of divestment of Singapore Food business and closure of Mannings China
7 Excluding impacts of divestment of Singapore Food business, closure of Mannings China and disposal of minority stake of Robinsons Retail
8 Excluding cigarettes under Convenience and IKEA Food
9 Excluding Mannings China
10 Excluding Singapore Food business
11 Excluding Singapore Food and Mannings China
Hashtag: #DFIRetailGroup #Mannings #Guardian #7-Eleven #Wellcome #MarketPlace #IKEA #yuu #Maxim’s
The issuer is solely responsible for the content of this announcement.
DFI Retail Group (the Group) is a leading Asian retailer, driven by its purpose to ‘Sustainably Serve Asia for Generations with Everyday Moments’.
At 30 June 2026, the Group and its associates operated 7,659 outlets across 12 markets, of which 5,593 stores were operated by subsidiaries. The Group, together with its associates, employed over 81,000 people, with more than 43,000 people employed by subsidiaries. The Group had reported revenue of US$8.9 billion in 2025.
The Group is committed to delivering quality, value and service to consumers across the region through trusted brands, strong local market positions, and a broad retail ecosystem supported by extensive store networks, digital capabilities and efficient supply chains.
The Group and its associates operate a portfolio of well-known brands across five key divisions. The principal brands are:
Health and Beauty
Convenience
Food
Home Furnishings
Restaurants
The Group’s parent company, DFI Retail Group Holdings Limited, is incorporated in Bermuda and has a primary listing in the equity shares (transition) category of the London Stock Exchange, with secondary listings in Bermuda and Singapore. The Group’s businesses are managed from Hong Kong. DFI Retail Group is a member of the Jardine Matheson group.
Damaged fat cells may help drive diabetes by losing their capacity to store lipids safely, becoming inflamed and eventually disappearing, research into a rare inherited disorder has found. The findings challenge the idea that metabolic disease is caused only by having too much body fat. They show that losing healthy adipose tissue can also destabilise blood sugar regulation by forcing fat into organs that are poorly equipped […]
Cryptocurrency markets face renewed volatility as an Ethereum developer warns that expectations surrounding the United States’ CLARITY Act could trigger a deeper sell-off if lawmakers fail to deliver the regulatory breakthrough already anticipated by traders. Econar, a long-time Ethereum builder and commentator, said digital assets could stage only a limited rise as speculation about the legislation intensifies. Failure to pass the bill could then push prices below […]
Bitcoin derivatives traders are rebuilding bullish positions, creating a multibillion-dollar liquidation risk if the cryptocurrency reverses sharply towards $58,200, while an accompanying warning about Ether falling to $1,700 has been overtaken by market prices. Bitcoin was trading near $65,400 on Friday, July 24, after reaching an intraday high of about $65,750 and falling as low as $64,636. A decline to $58,200 would therefore amount to a drop […]
Gulf Cooperation Council banks are bracing for slower growth as the Middle East war and wider geopolitical uncertainty weigh on credit demand, investor confidence and corporate activity, even as lenders retain strong profitability, capital buffers and stable funding. S&P Global Ratings analyst Tatjana Lescova said banks across the six-nation bloc are expected to continue delivering solid earnings despite pressure from the conflict, higher risk premiums and uneven […]
Bitcoin, Ether and other large crypto tokens are moving in unusually tight formation as a market worth more than $2.2 trillion tries to recover from a bruising correction, raising fresh questions over whether investors are gaining diversification or merely holding different versions of the same risk trade. Live market data showed Bitcoin, Ethereum, XRP, BNB, Solana, Dogecoin, Tron and Hyperliquid’s HYPE controlling roughly $1.74 trillion in combined […]
Opera has rolled out Paste Protect, a built-in browser defence designed to stop malicious clipboard commands before users can paste them into terminals, run boxes or other command-line tools. The feature, launched on 2 July 2026 and switched on by default in Opera’s desktop browsers, targets a fast-growing class of social engineering attacks known as ClickFix. These scams usually begin with a familiar-looking prompt: a failed video […]
TAIPEI, TAIWAN – Media OutReach Newswire – 2 July 2026 – Bora Pharmaceuticals Co., Ltd. (“Bora” or “Bora Group”; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.
With the close of the transaction, Bora Group’s biologics CDMO franchise, Bora Biologics, now operates 20,000 liters of single-use bioreactor (SUB) drug substance manufacturing capacity across two active US sites: Rockville, Maryland and San Diego, California, and one development facility in Zhubei, Taiwan.
“This acquisition establishes a US biologics manufacturing platform that sponsors can depend on, from development through licensed commercial supply,” said Bobby Sheng, Chairman and CEO of Bora Group. “As regulatory and supply chain dynamics continue to evolve, we expect biotech and pharmaceutical companies to increasingly seek manufacturing partners with US-based, inspection-proven infrastructure. Bora Biologics is designed to meet that need, offering a fully integrated, end-to-end biologics platform spanning drug substance and drug product capabilities.”
With the addition of the Rockville facility, Bora Biologics supports more than 4 active commercial programs, with more than 120 completed GMP batches and supply into multiple global markets including the US, EU, Japan, Canada and the UK with fully integrated QC and analytical capabilities.
Across its US network, Bora Biologics has completed five FDA inspections, including two at Rockville and one PMDA review in 2025, with clean results at both sites. The combined platform has supported more than 33 biologics and 15 biosimilars, establishing a manufacturing base for biotech and pharmaceutical companies with reduced offshore dependency and domestically anchored infrastructure.
Bora Group intends to integrate its US drug substance (DS) capabilities with its existing sterile drug product (DP) capabilities over the next 12 to 18 months, offering a seamless, fully integrated development-through-commercial biologics solution.
Hashtag: #BoraPharmaceuticals
The issuer is solely responsible for the content of this announcement.
Founded in 2007, Bora Pharmaceuticals (“Bora” or “the Company”, 6472.TW and BORAY.OTCQX) is a leading pharmaceutical services company with a vision and goal of “Contributing to Better Health All Over the World”. Operating under a “Dual Engine” model that integrates CDMO and commercial expertise, we empower pharmaceutical and biotech partners to optimize product development, accelerate launches, and scale supply to meet global patient needs. At the same time, we actively broaden R&D and sales infrastructure, focusing on niche and rare disease markets to improve patients’ quality of life.
By investing in talent, infrastructure, and biologics expansion, Bora continues to transform operations and achieve sustainable growth. Committed to making success “certain,” Bora sets new standards in the pharmaceutical and CDMO industries.
For more, please visit:
https://www.bora-corp.com
https://www.boracdmo.com
Disclaimer:
This document and the accompanying information may contain forward-looking statements. All statements regarding the company’s future business operations, potential events, and prospects (including but not limited to forecasts, targets, estimates, and operational plans) are considered forward-looking statements unless they refer to factual occurrences. Forward-looking statements are subject to various factors and uncertainties that may cause significant differences from actual results, including but not limited to price fluctuations, actual demand, exchange rate variations, market share, competitive conditions, changes in the legal, financial, and regulatory framework, international economic and financial market conditions, political risks, cost estimates, and other risks and variables beyond the company’s control. These forward-looking statements are based on current predictions and assessments, and the company disclaims any responsibility for future updates.
Private foreign investment in Saudi Arabia’s private markets reached SR20 billion in 2025, making overseas capital a dominant force in the Kingdom’s fast-expanding private investment landscape as reforms, larger deal pipelines and stronger exit prospects draw more global fund managers to Riyadh. The Saudi Venture Capital Company said foreign inflows accounted for about 60 per cent of total private investments last year, putting the overall market near […]
Investors heading into the second half of 2026 face an uncomfortable reality: the global economy is changing faster than many portfolios are adapting to it. The forces reshaping markets today are structural. AI is triggering one of the largest capital investment booms in modern history. Digital assets have crossed into mainstream finance. Meanwhile, geopolitical conflict, sovereign debt and valuation risk continue to create significant uncertainty. As the […]
France and Oman have moved to reinforce free and safe navigation through the Strait of Hormuz, rejecting any mandatory transit fee or political condition on vessels using one of the world’s most critical energy corridors. The position emerged during Sultan Haitham bin Tarik’s official visit to Paris, where he held talks with President Emmanuel Macron on maritime security, mine-clearance operations and diplomatic efforts to stabilise the Gulf […]
Arabian Post Staff -Dubai Iran has rejected French involvement in clearing mines from the Strait of Hormuz, declaring that Tehran alone will manage security operations in the strategic waterway under its memorandum of understanding with the United States. The rejection, delivered by Deputy Foreign Minister Kazem Gharibabadi, followed President Emmanuel Macron’s offer for France to work with Oman and other partners on demining and safe passage through […]
Deepening “Corporate Leadership, On-Site Implementation” to Reflect Excellent Governance Standards
Entering its sixth edition, the Awards continue to uphold their mission of creating a credible exchange platform for industry elites. In recent years, with society’s high emphasis on occupational safety and health, along with the widespread application of smart construction technologies, site safety has gone far beyond the traditional, rigid mindset of “checking in and re-inspecting”. The Institute thoroughly understands that excellent site safety performance does not rely solely on the routine compliance execution of frontline sites; it must stem from the forward-looking vision and comprehensive policy drive of corporate management.
To this end, this year’s Awards have comprehensively enhanced the judging criteria. Building upon the existing award categories, the judging perspective has been extended from frontline construction management to the macro corporate level, significantly increasing the weight of the “Safety” element in scoring to elevate industry standards. This edition will more comprehensively and deeply review the effectiveness of corporations in formulating and implementing safety management policies. In addition to frontline execution capabilities, the judging panel will place greater emphasis on how corporations promote an excellent construction safety culture from a policy level, including integrating tech solutions like Smart Site Safety Systems (SSSS) into long-term development strategies to safeguard site safety. Furthermore, special emphasis is placed this year on how corporations establish long-term accident prevention and continuous improvement mechanisms through institutional frameworks, embedding safety concepts into the core of corporate governance to lead a comprehensive transformation of the safety culture in Hong Kong’s construction industry.
Inaugural “Excellent Construction Safety Culture Award” with a Dedicated Judging Panel Establishes Industry Authority
Cr Alfred TANG, President of the Hong Kong Institute of Construction Managers, stated: “Site safety has always been the core focus most valued by the Government and the Institute. The Institute firmly believes that ‘Corporate Leadership, Safety Implementation, Everyone’s Responsibility’ is the key to driving industry transformation. To encourage more developers, main contractors, and stakeholders to actively play a top-down driving role, this year’s Awards have introduced the ‘Excellent Construction Safety Culture Award’, supported by an independent ‘Dedicated Safety Judging Panel’ composed of top senior safety experts and consultants in the industry to review the long-term effectiveness of corporate safety policies from the most rigorous and professional perspective. We firmly believe that this brand-new award and dedicated judging mechanism will effectively drive continuous progress in Hong Kong’s construction industry, laying a solid foundation for building a sustainable, safe, and highly efficient future.”
The “Construction Management Awards 2026” is opening for nominations from today until 31 August 2026. For details about the Awards, nomination forms, and judging criteria, please visit the Awards website (www.hkicm-cma.com).
Award Categories Overview
| Award Categories | Team / Corporate Awards | Corresponding Individual Award Categories |
| Building Project | Excellent Construction Team Award (Building Project) | A) Construction Manager Award B) Site Manager Award C) Engineer Award D) EHS Officer Award E) Construction Supervisor Award |
| Civil Project | Excellent Construction Team Award (Civil Project) | A) Construction Manager Award B) Site Manager Award C) Technical Manager Award D) Engineer Award E) EHS Officer Award F) Construction Supervisor Award |
| Corporate Project | A) Excellent Construction Safety Culture Award B) Excellent Construction Innovation Enterprise |
/ |
| Individual Project | / | Young Construction Manager Award |
Jury Panel
Chairman of the Judging Panel (Building Project):
Mr HO Chun Hung, JP, Director of Buildings, Buildings Department, HKSARG
Members of the Judging Panel (In apathetical order of surnames):
Chairman of the Judging Panel (Civil Project):
Mr HO Ying Kit, Tony, JP, Deputy Secretary for Development (Works) 3, Development Bureau, HKSARG
Members of the Judging Panel (In apathetical order of surnames):
Members of the Excellent Construction Safety Culture Award Judging Panel (In alphabetical order of surnames):
Hashtag: #HKICM
The issuer is solely responsible for the content of this announcement.
Established in 1997 with the sovereignty handover, Hong Kong Institute of Construction Managers (“Institute” or “HKICM”) is the only local professional institution representing the construction management profession in Hong Kong. The Institute has developed rapidly, with its members reached 3,439, of which 1,285 were Corporate Members (including Fellows and Members).
Our objectives are to secure the advancement and facilitate the acquisition of knowledge and expertise which constitutes and promotes the practice of and professionalism in construction management. The works of the Institute include setting standards for professional services and performance, establishing rules of conduct, promoting Registered Construction Managers and Construction Supervisors and promulgating the recognition of professional site supervisors. We believe that all construction sites need to be managed by registered professional construction managers to ensure compliance of operation with government laws, safety and environmental protection requirements. In order to improve the professional standard of technical personnel in an orderly manner, the government needs to register and recognize the professional qualifications of site supervisors.
Bitcoin slipped below $60,000 in the final week of June as digital assets endured one of their sharpest weekly reversals of the year, with Dogecoin, XRP and Solana showing relative resilience while broader market sentiment weakened under pressure from interest-rate expectations, a stronger dollar and fund outflows. The largest cryptocurrency changed hands near $59,873 after briefly falling through a level watched closely by traders for signs of […]
